Biosensors (B20.SG) +17.2% at $0.985, highest level since January 2008, on robust volume. Interest piqued by two bullish broker reports, according to Dow Jones.

Nomura, which has Buy call with $1.20 target, flags next week’s Hong Kong listing of MicroPort Scientific, which makes equipment for keyhole surgery, as catalyst for Singapore heart-stent maker.

Citing its own channel checks, Nomura says MicroPort’s IPO heavily over-subscribed, with price likely to be finalised at high of indicative range, which would yield 25x FY10 P/E, higher than 18x P/E at which Biosensors now trades: “We believe Biosensors may benefit from the spillover demand.”

Meanwhile, DBS Vickers has started coverage with Buy call with $1.20 target. Spike in volume, highest since May 2007, indicates strong momentum, which may carry gains over to next week, although RSI’s showing of overbought condition may prompt some profit-taking in near term. Orderbook quotes suggest $1.00 resistance for time being.